Artículos por temáticas

The Neurologic Manifestations of Coronavirus Disease 2019 Pandemic: A Systemic Review

Tsai ST, Lu MK, San S, Tsai CH.

Front Neurol. 2020 May 19;11:498. doi: 10.3389/fneur.2020.00498. eCollection 2020.

COVID-19 Pandemic: A Neurological Perspective

Lahiri D, Ardila A.

Cureus. 2020 Apr 29;12(4):e7889. doi: 10.7759/cureus.7889.

Neurological manifestations of COVID-19

Kanwar D, Baig AM, Wasay M.

J Pak Med Assoc. 2020 May;70(Suppl 3)(5):S101-S103. doi: 10.5455/JPMA.20.

Cerebellar Scholars' Challenging Time in COVID-19 Pandemia

Shaikh AG, Mitoma H, Manto M.

Cerebellum. 2020 Jun;19(3):343-344. doi: 10.1007/s12311-020-01131-9.

COVID-19-Associated Bifacial Weakness with Paresthesia Subtype of Guillain-Barré Syndrome

Hutchins KL, Jansen JH, Comer AD, Scheer RV, Zahn GS, Capps AE, Weaver LM, Koontz NA.

AJNR Am J Neuroradiol. 2020 Sep;41(9):1707-1711. doi: 10.3174/ajnr.A6654. Epub 2020 Jun 25.

COVID-19-associated mild encephalitis/encephalopathy with a reversible splenial lesion

Hayashi M, Sahashi Y, Baba Y, Okura H, Shimohata T.

J Neurol Sci. 2020 May 27;415:116941. doi: 10.1016/j.jns.2020.116941. Online ahead of print.

Medical and Paramedical Care of Patients With Cerebellar Ataxia During the COVID-19 Outbreak: Seven Practical Recommendations of the COVID 19 Cerebellum Task Force

Manto M, Dupre N, Hadjivassiliou M, Louis ED, Mitoma H, Molinari M, Shaikh AG, Soong BW, Strupp M, Van Overwalle F, Schmahmann JD.

Front Neurol. 2020 May 22;11:516. doi: 10.3389/fneur.2020.00516. eCollection 2020.

Does SARS-CoV-2 infection cause chronic neurological complications?

Hascup ER, Hascup KN.

Geroscience. 2020 May 25:1-5. doi: 10.1007/s11357-020-00207-y. Online ahead of print.

Consensus Statement of the Saudi Association of Neurological Surgery (SANS) on Triage of Neurosurgery Patients During COVID-19 Pandemic in Saudi Arabia

Bajunaid K, Sabbagh AJ, Ajlan A, Al-Jehani H, Alnaami I, Khormi YH, Bin Mahfoodh M, Barnawi A, Bin Salamah A, Alobaid A, Bafaquh MS, Alturki AY, Alkhani A, Al-Habib H, Baeesa S, Al-Habib A.

Neurosciences (Riyadh). 2020 Apr;25(2):148-151. doi: 10.17712/nsj.2020.2.20200054.

Safety considerations for neuraxial anaesthesia in parturients with COVID-19

Sun X, Liu Y, Mei W.

Br J Anaesth. 2020 Sep;125(3):e313-e314. doi: 10.1016/j.bja.2020.05.005. Epub 2020 May 14.

Comment on "Central Nervous System Involvement by Severe Acute Respiratory Syndrome Coronavirus -2 (SARS-CoV-2)"

Chen S, Lu H, Liu Z, Yuan W.

J Med Virol. 2020 May 8:10.1002/jmv.25991. doi: 10.1002/jmv.25991. Online ahead of print.

Imaging of Neurologic Disease in Hospitalized Patients with COVID-19: An Italian Multicenter Retrospective Observational Study

Mahammedi A, Saba L, Vagal A, Leali M, Rossi A, Gaskill M, Sengupta S, Zhang B, Carriero A, Bachir S, Crivelli P, Paschè A, Premi E, Padovani A, Gasparotti R.

Radiology. 2020 Nov;297(2):E270-E273. doi: 10.1148/radiol.2020201933. Epub 2020 May 21.

Consensus Statement On Immune Modulation in Multiple Sclerosis and Related Disorders During the COVID-19 Pandemic: Expert Group on Behalf of the Indian Academy of Neurology

Bhatia R, Srivastava MVP, Khurana D, Pandit L, Mathew T, Gupta S, Netravathi M, Nair SS, Singh G, Singhal BS.

Ann Indian Acad Neurol. 2020 Apr;23(Suppl 1):S5-S14. doi: 10.4103/0972-2327.282442. Epub 2020 Apr 13.

European Society of Minimally Invasive Neurological Therapy (ESMINT) recommendations for optimal interventional neurovascular management in the COVID-19 era

Aggour M, White P, Kulcsar Z, Fiehler J, Brouwer P.

J Neurointerv Surg. 2020 Jun;12(6):542-544. doi: 10.1136/neurintsurg-2020-016137. Epub 2020 Apr 17.

Proposed Intranasal Route for Drug Administration in the Management of Central Nervous System Manifestations of COVID-19

Siddiqui R, Khan NA.

ACS Chem Neurosci. 2020 Jun 3;11(11):1523-1524. doi: 10.1021/acschemneuro.0c00288. Epub 2020 May 20.